Acorah Software Products - Accounts Production 19.3.600 false true 30 September 2024 1 October 2023 false true No description of principal activity 1 October 2024 31 March 2026 31 March 2026 12868483 R Thompson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12868483 2024-09-30 12868483 2026-03-31 12868483 2024-10-01 2026-03-31 12868483 frs-core:CurrentFinancialInstruments 2026-03-31 12868483 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2026-03-31 12868483 frs-bus:FilletedAccounts 2024-10-01 2026-03-31 12868483 frs-bus:Micro-entities 2024-10-01 2026-03-31 12868483 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2026-03-31 12868483 frs-bus:Director1 2024-10-01 2026-03-31 12868483 2023-09-30 12868483 2024-09-30 12868483 2023-10-01 2024-09-30 12868483 frs-core:CurrentFinancialInstruments 2024-09-30
Registered number: 12868483
Molecular Hepatology Ltd
Unaudited Financial Statements
For the Period 1 October 2024 to 31 March 2026
Nichols & Co (Accountancy) Limited
Molecular Hepatology Ltd
Balance Sheet
As At 31 March 2026
Balance Sheet
Registered number: 12868483

| 31 March 2026 | 30 September 2024
--- | --- | ---
|  | £ | £
Fixed assets |  | 685 | 1,097
Current assets |  | 11,878 | 33,084
Creditors: Amounts Falling Due Within One Year |  | (1,545 ) | (4,278 )
NET CURRENT ASSETS |  | 10,333 | 28,806
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 11,018 | 29,903
Accruals and deferred income |  | (2,725 ) | (2,703 )
NET ASSETS |  | 8,293 | 27,200
CAPITAL AND RESERVES |  | 8,293 | 27,200

## Notes

1. General Information
Molecular Hepatology Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12868483 . The registered office is Unit 7, Mulberry Place, Pinnell Road, Eltham, London, SE9 6AR.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL (2024: NIL)
- -
For the period ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

R Thompson Director
12/06/2026